The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

about

The use of rotation to fentanyl in cancer-related pain.The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development.Practical management of opioid rotation and equianalgesia

P2860

Q34551750-2DBDF9EB-1ACD-4C9E-8DAF-D60C76786860 Q36733590-CCED8B12-0BE7-4306-BBC2-E5E2891C7436 Q59126151-C5320B1A-02C8-481C-A39E-C3F83452081D

P2860

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

Item

http://www.wikidata.org/entity/Q40449086

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

@en

type

Item

label

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

@en

prefLabel

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

@en

P1476

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

@en

P2093

Akhila Reddy

http://www.w3.org/2001/XMLSchema#string

Ali Haider

http://www.w3.org/2001/XMLSchema#string

Angelique Wong

http://www.w3.org/2001/XMLSchema#string

Carolyn Holmes

http://www.w3.org/2001/XMLSchema#string

Diane Liu

http://www.w3.org/2001/XMLSchema#string

Eden Mae Rodriguez

http://www.w3.org/2001/XMLSchema#string

Janet Williams

http://www.w3.org/2001/XMLSchema#string

Jessica Waletich

http://www.w3.org/2001/XMLSchema#string

Jimin Wu

http://www.w3.org/2001/XMLSchema#string

Kimmie Tallie

http://www.w3.org/2001/XMLSchema#string

P2860

Review and critique of opioid rotation practices and associated risks of toxicity

Role of active metabolites in the use of opioids

Methadone initiation and rotation in the outpatient setting for patients with cancer pain

Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer.

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

Overdose deaths demand a new paradigm for opioid rotation.

Opioid rotation for toxicity reduction in terminal cancer patients.

Switching from methadone to a different opioid: what is the equianalgesic dose ratio?

Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing.

Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use

P304

149-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.29688

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Joseph A. Arthur

Eduardo Bruera

P577

2015-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26451687

http://www.w3.org/2001/XMLSchema#string

P921

fentanyl

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

about

P2860

P2860

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921